In 2006 an otherwise healthy 76-year-old woman presented to her general practitioner (GP) with a pigmented skin lesion on her right calf below the popliteal fossa. The GP took a 5 mm biopsy of this lesion, which was reported as a superficial spreading melanoma with a Breslow thickness of 0.6 mm.
In 2006 an otherwise healthy 76-year-old woman presented to her general practitioner (GP) with a pigmented skin lesion on her right calf below the popliteal fossa. The GP took a 5 mm biopsy of this lesion, which was reported as a superficial spreading melanoma with a Breslow thickness of 0.6 mm.
There was a family history of a brother age 80 and a son aged 23 both succumbing to melanoma with cerebral metastases.
The patient was referred to a surgeon and wide margin excision was discussed, but she declined to undergo surgery and subsequently purchased black salve via the Internet, applying it to the melanoma under a closed dressing for 24 hours.
This caused localized inflammation and ulceration, and the ulcer reportedly healed over a period of six to eight weeks. In 2011, five years later, when the patient presented for a routine skin check, a small dark blue firm nodule with surrounding skin discoloration was noticed on her right calf at the site of the biopsied melanoma ( Figure 1A ). Arrangements were made for an excisional biopsy, but the patient did not attend.
Five months later the patient re-presented with a fungating nodular lesion in the right calf ( Figure 1B) . A provisional diagnosis was made of melanoma with a nodular component and after discussion with the patient she was referred to a surgeon for excision of the lesion and consideration of sentinel node biopsy. The patient did not attend these appointments but purchased black salve via the Internet and applied it to the lesion. Three weeks later the patient re-presented to her GP with a large eschar on her right calf that was removed to reveal an ulcer and a pink nodule with surrounding erythema. The patient agreed to radiotherapy in an attempt to shrink the right inguinal mass to relieve the peripheral edema of Mohs' original formula included zinc chloride, bloodroot and antimony sulphide [3] . The ingredient zinc chloride is a strong escharotic and has been used for the debridement of chronic leg ulcers and for chemo-surgical debridement of osteolytic bone [4] . The other major ingredient Sanguinaria canadensis is a perennial flowering plant native to North Eastern America and the ingredient is known colloquially as bloodroot, Indian Paint and redroot [2] . When the root is harvested and cut, a red liquid drains which thickens to a paste. This paste is also a strong escharotic and has been used by indigenous
Americans to treat warts, polyps and moles [2] . The active ingredient in the bloodroot rhizome is a benzyl isoquinolone alkaloid [BIA]. BIA's are a diverse group of specialized plant metabolites that includes approximately 2,500 known structures including the narcotic analgesics morphine and codeine.
Sanguinarine contains antimicrobial properties [5] , and invitro studies show that it also contains potent anti-cancer properties [6] . A recently published research article has shown that sanguinariine is a rapid inducer of melanoma caspasedependent cell death that is mediated by oxidative stress [7] . Despite arguable molecular rationale for the topical application of these natural compounds, preclinical and clinical data in this field are still scant and no controlled clinical trial has yet been published demonstrating any relevant clinical efficacy.
One brand of black salve, Cansema (manufacturer Omega Alpha Labs), is marketed on the Internet as "…a miraculous product with a miraculous history with roots that go back to the late 19th century." The advertisement goes on to state:
"Only suppression and greed have prevented its enormous benefits from being made available to the mainstream" [8] . Many testimonials praising the results of Cansema are also listed on the Internet [9] . It is likely that some patients researching cancer treatments on the Internet might not be aware that testimonials are not valid scientific proof. It has been argued by one author that "When they read that the Mohs technique offers the highest known cure rate for skin cancer and that the salve for sale is identical to Dr. Mohs'
original formula it is fair to assume that some will infer that the salve available for sale produces the stated cure rates" [3] .
The Australian Government has issued warnings to consumers about the use of black and red salves in treating cancer and, in an authoritative warning, states, "The TGA is not aware of any credible, scientific evidence which shows that any black or red salve preparation is effective in treating cancer" [10] .
The case presented here involves a patient who, having had an initial diagnosis of thin invasive melanoma, decided to follow the option of an alternative cancer treatment rather than conventional evidence based treatment.
The reason the patient gave for seeking alternative treatment in 2006 was the cost of immediate surgical management in the Australian private health system. When she failed to attend this private appointment, her GP contacted her. The GP then arranged for her to be seen in the local public hospital at no cost, though there was going to be a delay of a couple of weeks for the appointment. Once again the patient did not attend this appointment. At that time the patient was reportedly also encouraged by an acquaintance to use black salve.
It is speculation, but perhaps having witnessed the death of her brother at age 80 and her own son at age 23 from cerebral metastatic melanoma, the patient was in denial of her own disease. As it turned out, there was a time delay of seven years before she agreed to conventional management of her melanoma.
During this time there were consultations with three GPs, three surgeons, one dermatologist, one radiologist and an oncologist. The patient exercised the undisputed right to follow the treatment regimen of personal choice. Over a period of seven years the disease progressed both locally and systemically. It is not known whether distant metastases were already present at the time of original diagnosis, but based on the staging of the tumor (Stage 1), the prognosis for 10-year disease-free survival was 87.9% [11] . Ten-year survival prognosis for Stage 4 melanoma (lung metastases) is 2.5% [11] .
We believe it is essential that patients are adequately informed about evidence-based treatment and warned about the potential adverse consequences associated with an alternative treatment regimen but we also believe that support should continue to be provided regardless of choices made.
